Caplin Point slides 13% in 3 sessions after US FDA flags plant for action

US FDA classified the Gummidipoondi facility as OAI, indicating that the FDA believes the inspection findings warrant regulatory action
Key takeaways
- Category: Stocks.
Why it matters
A routine update. Use the price and stock snapshot to gauge how the market is responding.






